These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9512218)

  • 21. Thiazolidinediones for treatment of polycystic ovary syndrome.
    Stout DL; Fugate SE
    Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystic ovary syndrome.
    Ehrmann DA
    N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
    [No Abstract]   [Full Text] [Related]  

  • 23. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
    Dunaif A; Scott D; Finegood D; Quintana B; Whitcomb R
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3299-306. PubMed ID: 8784087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-lowering medications in polycystic ovary syndrome.
    Taylor AE
    Obstet Gynecol Clin North Am; 2000 Sep; 27(3):583-95. PubMed ID: 10958005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin and polycystic ovary syndrome.
    Lebinger TG
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):132-40. PubMed ID: 17940431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular effects of the thiazolidinedione troglitazone].
    Yamada K; Kuzuya H; Nakano T
    Nihon Rinsho; 2000 Feb; 58(2):435-9. PubMed ID: 10707572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
    Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI
    N Engl J Med; 1998 Mar; 338(13):867-72. PubMed ID: 9516221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comment: troglitazone.
    Fraser CG; Fierro L
    Ann Pharmacother; 1998 Oct; 32(10):1111-2. PubMed ID: 9793612
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of hyperinsulinemia in pathogenesis of polycystic ovary syndrome and treatment by reduction of insulin secretion].
    Wang A; Li M; Lu C
    Zhonghua Fu Chan Ke Za Zhi; 1998 Dec; 33(12):731-4. PubMed ID: 10806662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of hyperinsulinemia after pancreas transplantation in rats.
    Nakai I; Uchiyama K; Mitsuo M; Mizuta N; Okamoto M; Nakajima H; Yoshimura N; Omori Y; Oka T
    Transplant Proc; 1999 Aug; 31(5):2010-1. PubMed ID: 10455956
    [No Abstract]   [Full Text] [Related]  

  • 31. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
    J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
    Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
    N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troglitazone.
    Santiago JV
    Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible troglitazone-warfarin interaction.
    Plowman BK; Morreale AP
    Am J Health Syst Pharm; 1998 May; 55(10):1071. PubMed ID: 9606460
    [No Abstract]   [Full Text] [Related]  

  • 35. New diabetes drug targets insulin resistance.
    Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
    [No Abstract]   [Full Text] [Related]  

  • 36. Leptin concentrations in the polycystic ovary syndrome.
    Mantzoros CS; Dunaif A; Flier JS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1687-91. PubMed ID: 9177364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advisory panel hears contradictory evidence, backs keeping troglitazone on market.
    Miller JL
    Am J Health Syst Pharm; 1999 May; 56(9):840, 842. PubMed ID: 10344603
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of troglitazone in treating the insulin resistance syndrome.
    Granberry MC; Schneider EF; Fonseca VA
    Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troglitazone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model.
    Yao L; Mizushige K; Noma T; Murakami K; Ohmori K; Matsuo H
    Heart; 2000 Aug; 84(2):209. PubMed ID: 10908265
    [No Abstract]   [Full Text] [Related]  

  • 40. [Insulin-sensitizing agent].
    Yamanouchi T
    Nihon Rinsho; 1999 Mar; 57(3):675-80. PubMed ID: 10199153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.